The Research Initiative Program by NTSAD funds research to advance understanding and treatment of Tay-Sachs, Canavan, GM1, and Sandhoff diseases through innovative science and collaboration.
The Tau Pipeline Enabling Program V funds translational research to develop and advance therapies targeting tauopathies, led by the Alzheimer's Association.
The PMSF Research Grants Program funds innovative basic and clinical research to advance understanding and treatment of Phelan-McDermid syndrome, supported by the Phelan-McDermid Syndrome Foundation.
The Pittsburgh Foundation’s Medical Research grant funds innovative scientific studies on major diseases to improve public health in the Pittsburgh region.
2027 Next Generation Research Grants support early-career researchers conducting disease-specific and cross-condition neurological investigations to help launch academic careers in neurological research.